VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.27% | -22.75% | |||
| Depreciation & Amortization | -- | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.93% | -84.80% | |||
| Operating Income | -4.93% | -150.74% | |||
| Income Before Tax | -5.21% | -149.63% | |||
| Income Tax Expenses | -50.50% | -140.40% | |||
| Earnings from Continuing Operations | 4.23% | -152.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.23% | -152.08% | |||
| EBIT | -4.93% | -150.74% | |||
| EBITDA | -5.10% | -149.09% | |||
| EPS Basic | 0.00% | -153.85% | |||
| Normalized Basic EPS | -20.00% | -145.45% | |||
| EPS Diluted | 0.00% | -153.85% | |||
| Normalized Diluted EPS | -20.00% | -145.45% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||